EZH2 and breast carcinoma: Furthermore, the samples from never-smoked patients harbor low level of EZH2 irrespective of ductal or lobular type of cancer tissue in comparison to smoking-associated breast cancer tissue samples, which minimizes the role of inter-tumoral heterogeneity in EZH2 expression level.